GBA1 and Parkinson disease: The significant correlation between the severity of the specific GBA1 mutation and that of clinical phenotypes (e.g., odds ratios for PD, age at onset, risk for dementia) has been reported (145, 147, 154), suggesting major impact of GCase activity in the pathogenetic processes.